Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Agomelatine may help reduce benign prostatic hyperplasia by blocking certain inflammatory pathways.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Naltrexone did not significantly reduce hair pulling but improved cognitive flexibility.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

LPA3 is crucial for embryo implantation and links LPA to prostaglandin signaling.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Torilin from Torilis japonica can inhibit testosterone 5α-reductase but is less effective than finasteride.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

Not having the gene PLAAT3 leads to fat loss, high insulin resistance, and abnormal fat levels in the blood due to a disruption in fat cell development and function.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

Aromoline and DRD4 are potential targets for osteoarthritis treatment.

PEGylated thymosin β4 shows promise for treating heart attacks effectively.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

CTP-543 is generally safe for treating alopecia areata.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

mrp/plf-mRNA can indicate tumor-promoting effects in skin.

TTNPB helps turn stem cells into neural stem cells, improving depression-like behaviors in rats.

[6]-Gingerdiol 3-monoacetate shows promise for treating T. whipplei infections.

Tcf3 helps cells move and heal wounds by controlling lipocalin 2.

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.